logo
Plus   Neg
Share
Email

STADA FY17 Net Profit Down, Cuts Dividend; Sees Growth Ahead - Quick Facts

STADA Arzneimittel AG (STDAY.PK,STDAF.PK), a pharmaceutical company, reported Thursday that its fiscal 2017 net income reduced 1% to 85.3 million euros from 85.9 million euros last year. Earnings per share were 1.37 euros, down from 1.38 euros a year ago.

Adjusted net income was 195.6 million euros or 3.14 euros per share, compared to 177 million euros or 2.85 euros per share a year ago, mainly reflecting positive development of the operating profit in Belgium, Germany, Spain and Russia.

The adjusted EBITDA increased 9% to 433.9 million euros.

Group sales increased 8% to 2.31 billion euros from prior year's 2.13 billion euros. This rise was mainly due to the increase in the Belgian, Italian and Serbian Generics segment as well as in the Russian Branded Products segment. Group sales adjusted by currency and portfolio effects increased by 6%.

Further, STADA targets to accelerate growth and increase its ranking position in the global pharma market in the coming years. To achieve this target the Executive Board and the Supervisory Board of STADA consider it necessary, to significantly increase investments in R&D, new products, technologies and markets.

Against this backdrop, both bodies suggest to the General Meeting on June 6, 2018, to pay a dividend for the 2017 financial year of 0.11 euro per STADA share, down from previous year's 0.72 euro.

Looking ahead, the Executive Board expects further Group growth for financial year 2018 as compared to the prior year. Group sales adjusted for currency and portfolio effects are expected to be 2.495 billion euros plus or minus 5%, representing a growth in the high single digits adjusted for currency and portfolio effects. Adjusted EBITDA is expected to be 480 million euros plus or minus 5% and adjusted net income 230 million euros plus or minus 5%.

With regard to the strategic outlook for 2019, the Executive Board expects to be able to achieve adjusted Group sales of 2.575 billion euros bn plus or minus 5%, an adjusted EBITDA of 540 million euros plus or minus 5% and adjusted net income of 275 million euros plus or minus 5%.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A $716 billion defense policy bill easily cleared the Senate on Monday, although the legislation must still be reconciled with the version previously approved by the House. The Senate voted 85 to 10 in favor of the National Defense Authorization Act, which authorizes U.S. military spending for fiscal 2019. Voip-Pal.com Inc. has filed a lawsuit against Amazon Inc., accusing Alexa's calling and messaging services of infringing its patents. The lawsuit, filed by Voip-Pal in the U.S. District Court in Nevada, accuses Amazon's Alexa calling and messaging system of using Voip-Pal's patented technologies to direct voice/video calls and voice messages to both Amazon subscribers and non-subscribers. Canada is a step closer to becoming the first G-7 nation to legalize marijuana nationwide after the House of Commons voted to allow recreational use. The bill will now go back to the country's Senate, which had already approved a version of the bill. On Monday, the House of Commons voted 205 to 82 in favor of the Bill C-45, known as the Cannabis Act.
Follow RTT